tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro Feb 2026
Volume 14 issue 3

Why the Right Approach to Data Management Will Enable the Potential of Small-molecule RNA Sodifiers as Drug Targets to be Fulfilled

Over the past 5 decades or so, the growing understanding that RNA can influence protein function through routes other than direct translation has opened the prospect...
Continue Reading →
Volume 14 issue 3

Handling with Care: Aseptic Dip Coating for Osteoporosis Treatment

Kindeva Drug Delivery is a contract development and manufacturing organisation (CDMO) specialising in complex drug formulation and delivery. Seeking to scale its pro...
Continue Reading →
Volume 14 issue 3

Advances in Manufacturing and Processing Impacting Formulation Development

Achieving investigational new drug (IND) approval at an increasingly faster rate than competitor drugs is a widespread desire of biologics developers. This has been ...
Continue Reading →
Volume 14 issue 3

Testing Excipients for 3D Printed Pharamceuticals

3D printing or additive manufacturing (AM) technology has considerable potential to more closely align tablet manufacture with modern requirements and is a growing a...
Continue Reading →
Volume 14 issue 3

Flexible Manufacturing Environments are Vital for Today’s Potent Oral Dose Forms

Driven by advances in oncology treatments and personalised precision medicine, two trends are converging to increasingly challenge pharma's developers and their exte...
Continue Reading →
Volume 14 issue 3

Solid Form Services – Bridging the Gap Between Drug Substance and Drug Product

The solid form of a drug substance has a huge bearing on its formulation as a drug product. In an ideal world, every API would reliably form beautiful, homogeneous c...
Continue Reading →
Volume 14 issue 3

What’s in Store for Aseptic Processing Technologies in 2022 and Beyond?

By 2028, the global market for injectable drugs is set to reach $69.13 billion, growing at a CAGR of 8.9%. There are many reasons for this boom in demand, from the d...
Continue Reading →
Volume 14 issue 3

Modular Cleanroom Technologies Have Always Been the Answer to Biopharma’s Global Growth and Flexibility Needs

Modular building technologies have well proven to meet the pharmaceutical industry’s demanding capacity and speed imperatives. For the last three decades or more,...
Continue Reading →
Volume 14 issue 3

PCI Pharma Services – Robotic Aseptic Processing

The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative therapies, the co...
Continue Reading →
Volume 14 issue 3

How Product Inspection Drives Quality in Liquid Pharmaceuticals

In liquid pharmaceuticals, the stakes could not be higher: the correct dosage and usage can literally be a matter of life and death. Marco Pelka, Market Manager PCE ...
Continue Reading →
SAE Media – AI in DD
YPSOMED website ad
Scott Pharma – 25.03.2025
HCMed
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025